Pemazyre

(pemigatinib)
NO BOXED WARNING

Dosage & Administration

Cholangiocarcinoma:

Myeloid/lymphoid neoplasms with FGFR1 rearrangement:


All patients treated with PEMAZYRE:


Get Your Patient on Pemazyre

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Pemazyre Prescribing Information

Pemazyre Prior Authorization Resources

Most recent state uniform prior authorization forms

Benefits investigation

Reimbursement help (FRM)

Pemazyre Financial Assistance Options

Copay savings program

View more

Bridge program

View more

Foundation programs

View more

Pemazyre PubMed™ News

    Pemazyre Patient Education

    Patient toolkit

    Pemazyre FAQs